JKJohn M. Kittelson

John M. Kittelson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John M. Kittelson has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Katrina Sharples

    Department of Preventive and Social Medicine, University of Otago, PO Box 913, Dunedin, New Zealand

    1 shared publication
  • Scott S. Emerson

    Department of Biostatistics, Box 357232, University of Washington Seattle, Washington 98195, U.S.A.

    1 shared publication
  • Todd A. Alonzo

    Keck School of Medicine, University of Southern California Department of Biostatistics Los Angeles, CA 90033

    1 shared publication

Latest Publications

  • A Novel Design for Estimating Relative Accuracy of Screening Tests When Complete Disease Verification Is Not Feasible

    by Todd A. Alonzo, John M. Kittelson

    SummaryThe accuracy (sensitivity and specificity) of a new screening test can be compared with that of a standard test by applying both tests to a group of subjects in which disease status can be determined by a gold standard (GS) test. However, it is not always feasible to administer a GS test to all study subjects. For example, a study is planned to determine whether a new screening test for cervical cancer (“ThinPrep”) is better than the standard test (“Pap”), and in this setting it is not feasible (or ethical) to determine disease status by biopsy in order to identify women with and without disease for participation in a study. When determination of disease status is not possible for all study subjects, therelative accuracyof two screening tests can still be estimated by using a paired screen‐positive (PSP) design in which all subjects receive both screening tests, but only have the GS test if one of the screening tests is positive. Unfortunately in the cervical cancer example, the PSP design is also infeasible because it is not technically possible to administer both the ThinPrep and Pap at the same time. In this article, we describe a randomized paired screen‐positive (RPSP) design in which subjects are randomized to receive one of the two screening tests initially, and only receive the other screening test and GS if the first screening test is positive. We derive maximum likelihood estimators and confidence intervals for the relative accuracy of the two screening tests, and assess the small sample behavior of these estimators using simulation studies. Sample size formulae are derived and applied to the cervical cancer screening trial example, and the efficiency of the RPSP design is compared with other designs.


  • Group sequential clinical trials for longitudinal data with analyses using summary statistics

    by John M. Kittelson, Katrina Sharples, Scott S. Emerson